Product Description
Anti cancer Tablets
We offers all types of Branded Anti cancer Tablets.
We are distributors of well known multinational pharmaceutical company like Lupin, lilly, Cipla , Zydus, Pfizer, Dr reddy, strides shasun, Gilead, Astrazenaca, Serum Institute, Hetero, Cadilla, Geneca, Biocon, Sanofi, Sandoz, Novo Nordisk etc.
We can supply 5000 Unit of each brand monthly with needed documents.
we are giving 3-5 days delivery at affordabel price.
Precision Oncology Treatment for NSCLCGefitinib Tablets are formulated as a potent, targeted option for patients diagnosed with Non-Small Cell Lung Cancer. The mechanism focuses on inhibiting EGFR tyrosine kinase, disrupting cancer cell proliferation while sparing normal cells. This selectivity provides patients with a modern approach to cancer care and can be integrated into personalized oncology treatment plans as prescribed by healthcare professionals.
High-Standard Packaging and QualityEach strip of Gefitinib Tablets is securely packed in aluminum-aluminum blister strips. This meticulous packaging protocol not only preserves the integrity and strength of the active ingredients but also ensures protection from moisture and contaminants, thus maintaining safety and efficacy throughout its shelf life. The tablets are stored below 30C as per recommended guidelines.
Ease of Administration and ComplianceGefitinib Tablets offer convenient oral administration, supporting treatment compliance and ease of use for patients. Their designlight brown, round, and film-coatedfacilitates swallowing and accurate dosing. This ensures patients receive the full therapeutic benefit as directed by their oncologist, with minimal treatment disruption.
FAQs of Anti cancer Tablets:
Q: How are Gefitinib Tablets administered for treating NSCLC?
A: Gefitinib Tablets are taken orally, usually once daily, with or without food as directed by a healthcare provider. Patients should swallow the tablet whole with water and avoid crushing or splitting the tablet to ensure accurate dosage.
Q: What is the benefit of using Gefitinib Tablets in non-small cell lung cancer therapy?
A: Gefitinib Tablets act as targeted EGFR tyrosine kinase inhibitors, specifically blocking cancer cell growth in patients with certain genetic mutations. This tailored mechanism may offer improved outcomes and fewer systemic side effects compared to conventional chemotherapy.
Q: When should a patient begin therapy with Gefitinib Tablets?
A: Therapy with Gefitinib Tablets should commence only after a doctors prescription, following confirmation of EGFR mutations associated with Non-Small Cell Lung Cancer. The timing and duration are determined by the oncologist based on individual patient needs.
Q: Where should Gefitinib Tablets be stored to maintain their efficacy?
A: Gefitinib Tablets must be stored below 30C in their original aluminum-aluminum blister packaging. It is important to keep them protected from moisture and out of reach of children to ensure safety and maximum potency.
Q: What is the minimum order quantity and packaging for Gefitinib Tablets?
A: The minimum order quantity is one strip containing 10 tablets. Each tablet is individually sealed in a high-quality aluminum-aluminum blister strip, providing optimal protection for distribution and storage.
Q: How do I know if Gefitinib Tablets are suitable for my condition?
A: Suitability is determined by a healthcare professional based on genetic testing that identifies EGFR mutations in Non-Small Cell Lung Cancer. An oncologist will evaluate your medical history before prescribing Gefitinib.